View allAll Photos Tagged brainstorming
Fortune Brainstorm HEALTH 2018
March 19-20, 2018
Laguna Niguel, CA
The third Fortune Brainstorm HEALTH conference will be held March 19-20, 2018 in Laguna Niguel. We will again convene a powerful new community of leaders at the forefront of the revolution that is underway in 21st century healthcare.
2017 speakers included Joseph R. Biden, Jr., 47th Vice President, United States, CEOs Chip Bergh of Levi Strauss & Co. Mark Bertolini of Aetna, Tom Hayes of Tyson Foods, Arianna Huffington of Thrive Global, John Mackey of Whole Foods, Mike McNamara of Flex, Denise Morrison of Campbell Soup, and Timothy Wentworth of Express Scripts, as well as Duke University Surgical Oncologist (and Time 100 honoree) Dr. Shelley Hwang, Tempus Co-founder and Chair Eric Lefkofsky, Stanford University School of Medicine Dean Dr. Lloyd Minor, Venrock Partner Dr. Bryan Roberts, and Human Longevity Co-founder and Executive Chair Dr. J. Craig Venter. They were joined by our co-chairs—Fortune Editor-in-Chief Clifton Leaf, Time Executive Editor Siobhan O’Connor and Dr. David Agus, one of the world’s most influential physicians.
Fortune Brainstorm HEALTH, in association with IBM Watson Health, gathers not only C-suite leaders of top companies, hospitals, insurers, and cutting-edge pharma and biotech companies, but also titans of venture capital, tech and telecom, and other industries, all of who are rapidly changing the face of health care. The forum covered four pillars—personal wellness, intervention, research, and the value chain. Our aim is not only to push some boundaries in each of these areas, but also to show how businesses, both established and new, can lead the way. And, yes, as with all of our Brainstorm events, Fortune will disseminate these ideas on our website, in the magazine, on social media, and beyond.
Photograph by Stuart Isett/Fortune
042
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
4:30 PM
A SPECIAL CLOSING INTERVIEW: A CONVERSATION WITH KEVIN DURANT AND RICH KLEIMAN
Kevin Durant, Partner, The Durant Company; Thirty Five Media, Forward, Golden State Warriors
Rich Kleiman, Co-founder, The Durant Company; Thirty Five Media
Moderator:Arianna Huffington, Thrive Global
Photograph by Stuart Isett/Fortune
020
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
9:05 AM
THE NEXT ENDANGERED SPECIES: THE DOCTOR
Lost in the conversation of the digital health revolution is the focus on humans that often drive transformation in healthcare and that’s the medical doctor. We’ve seen doctors increasingly demoralized, depressed, and under pressure to meet mounting administrative loads while maintaining impeccable, patient-rated “healthgrades” online. The epidemic of burnout now affects almost two-thirds of America’s physicians according to a recent Medscape study. They’re frustrated by the payment systems and being pushed out by large health systems that imagine others doing their work and stripping them of authority. They spend less and less time with patients, and there’s giddy talk about how soon robots—already active in surgery and radiology—will do it all. Do we really want to imagine a world without doctors?
Dr. Toby Cosgrove, Former President and CEO, Cleveland Clinic
Dr. Laurie Glimcher, President and CEO, Dana-Farber Cancer Institute
Moderator: Dr. David B. Agus, University of Southern California
Photograph by Stuart Isett/Fortune
042
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
4:30 PM
A SPECIAL CLOSING INTERVIEW: A CONVERSATION WITH KEVIN DURANT AND RICH KLEIMAN
Kevin Durant, Partner, The Durant Company; Thirty Five Media, Forward, Golden State Warriors
Rich Kleiman, Co-founder, The Durant Company; Thirty Five Media
Moderator:Arianna Huffington, Thrive Global
Photograph by Stuart Isett/Fortune
Fortune Brainstorm Health
Wednesday, November 2, 2016
San Diego, CA
12:40 PM CONCURRENT LUNCHES: SOLUTION SESSIONS
HELP FROM AFAR: THE POWER OF REMOTE HEALTHCARE
Intervention Track Hosted By: Insigniam
Mobile technology is enabling doctors and patients to meet anytime and anywhere. Thanks to advances in telemedicine, physicians—even psychiatrists—can now monitor patients and do the kind of detailed patient workups and counseling that had once been possible only in an in-person visit. In theory, it’s easier for patients, it’s cheaper for healthcare systems, and the results (in early testing) seem just as good. So what’s stopping us from making remote healthcare the norm, especially for those with chronic diseases who need frequent monitoring? And how can other Uber-like platforms (doctors on demand) improve cost, efficiency, and the quality of care as well?
Firestarters:
Hill Ferguson, Chief Executive Officer, Doctor On Demand
Suneel Gupta, Head of Mobile, One Medical
Ron Gutman, Founder and CEO, HealthTap
Dr. Vivian S. Lee, Dean, School of Medicine; Senior Vice President, Health Sciences; CEO, University of Utah Health Care, University of Utah
Rick Valencia, President, Qualcomm Life, Qualcomm Inc.
Moderator: Leena Rao, Fortune
Photograph by Stuart Isett for Fortune Brainstorm Health
039
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
3:05 PM
SEEING AROUND THE CORNER: THE SEARCH FOR A UNIVERSAL FLU VACCINE
This year marks not only a particularly brutal flu season in the U.S., but also the 100th anniversary of the 1918 Spanish Flu. That historic pandemic infected 500 million people, killing 50 million — or five percent of the world’s population. With hundreds of thousands of people still dying annually from the seasonal flu, how long before a universal flu vaccine is a reality? We’ll hear from one leader working feverishly to make sure we’re protected next time a killer bug hits home.
Dr. Bruce Gellin, President, Global Immunization, Sabin Vaccine Institute
Photograph by Stuart Isett/Fortune
036
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
1:00 PM
CONCURRENT LUNCH SOLUTION SESSIONS
MEDICAL INGENUITY — AT HALF THE PRICE
Hosted by Abbott
One thing we are very good at: creating medical marvels. Not so good at: making them affordable. So how do you squeeze more value out of innovation? One answer is to bring affordability into the ideation and design process from the very beginning. A conversation that probes the least explored part of ingenuity: patient value.
Jeffrey Brewer, Co-founder, President and CEO,, Bigfoot Biomedical
Dr. Toby Cosgrove, Former President and CEO, Cleveland Clinic
Dr. Jiren Liu, Founder, Chairman, and CEO, Neusoft Corp.
Jared Watkin, Senior Vice President, Diabetes Care, Abbott
Moderator: Michal Lev-Ram, Fortune
Photograph by Stuart Isett/Fortune
040
FORTUNE Brainstorm Health 2019
April 3rd, 2019
San Diego, CA
2:47 PM
WHERE MENTAL HEALTH MEETS TECHNOLOGY
A conversation about how technology can help diagnose mental disorders sooner, identify optimal treatments faster and ultimately help more people lead healthier, happier lives. We’ll also explore the link between our society’s ubiquitous technology and mental health. How do we strike the right balance in using tech for good and controlling our devices, rather than the other way around?
Diesel Peltz, Founder and CEO, Twenty
Catherine Price, Science Journalist and Author, How to Break Up With Your Phone
Dr. Leanne Williams, Professor, Psychiatry and Behavioral Sciences, Stanford University
Moderator: Arianna Huffington, Thrive Global
Photograph by Stuart Isett for Fortune
001
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
11:30 AM–1:00 PM
OPENING LUNCH: THE MOMENT OF TRUTH FOR DRUG DEVELOPMENT
Hosted by PAREXEL
The rising cost of failure. Lack of productivity gains. Intense pressure on prices and escalating demands to demonstrate value. All these factors are threatening the sustainability of pharmaceutical development, at a time when advances in medical science should be translating into significant gains for the industry and society. But a new class of technologies and patient-centric approaches may soon alter the playing field in a big way, allowing drug developers to leverage everything from real world data, to the use of precision medicine and cross-silo collaboration—driving up success rates and the value proposition for new medicines. We dig into the latest marvels in pharmaceutical development, discuss new research findings and probe how the transformative role of data might prove decisive for the future of the industry.
Dr. Udit Batra, CEO, MilliporeSigma
David Humphreys, Head of Healthcare U.S., Economist Intelligence Unit
Bernard Munos, Senior Fellow, FasterCures, a center of the Milken Institute
Paul Rejto, Executive Director and Head of Oncology Translational Research, Pfizer
Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation
Moderator: Clifton Leaf, Editor-in-Chief, Fortune and Co-chair, Brainstorm Health
Introduction by: Dr. Alberto Grignolo, Corporate Vice President, Global Strategy, PAREXEL Consulting
Photograph by Stuart Isett/Fortune
038
Tuesday, July 17th, 2018
Fortune Brainstorm Tech
2:15 PM
AFTERNOON ROUNDTABLES
THE TRIUMPHS AND TRIBULATIONS OF TECH TRANSFORMATION
Overhaul the way an entire organization operates? Easier said than done. Leaders including top chief information, technology, and digital officers share tales from the trenches—from skills gaps to process problems to operational overhauls—and discuss what they wish they had known about embracing new technologies.
Speakers:
Marc Leibowitz, Johnson & Johnson
Jeremy King, CTO, Walmart Labs
Christine Landry, Group Chief Executive, Consumer and Industrials, Conduent
Cathy Polinsky, CTO, Stitch Fix
Lt. General Nadja Y. West, Surgeon General, U.S. Army
Moderator: Ellen McGirt, Senior Editor, Fortune
Photograph by Fortune Brainstorm Tech
024
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
10:05 AM
WHO’S THE BOSS?
In the digital health revolution, the patient is supposed to be king. But in a world where this consumer doesn’t pay for much of his or her care, isn’t confident about his or her knowledge of the marketplace, and doesn’t have that much choice anyway, can he or she really be in charge? (If the answer is no, how do we change this paradigm?)
Dr. Valerie Montgomery Rice, President and Dean, Morehouse School of Medicine
Christi Shaw, President, Lilly Bio-Medicines
Dr. Eric Topol, Founder and Director, Scripps Translational Science Institute; Executive VP and Professor, Molecular Medicine, The Scripps Research Institute
Moderator: Beth Kowitt, Senior Writer and Co-chair, MPW Next Gen, Fortune
Photograph by Stuart Isett/Fortune
024
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
10:05 AM
WHO’S THE BOSS?
In the digital health revolution, the patient is supposed to be king. But in a world where this consumer doesn’t pay for much of his or her care, isn’t confident about his or her knowledge of the marketplace, and doesn’t have that much choice anyway, can he or she really be in charge? (If the answer is no, how do we change this paradigm?)
Dr. Valerie Montgomery Rice, President and Dean, Morehouse School of Medicine
Christi Shaw, President, Lilly Bio-Medicines
Dr. Eric Topol, Founder and Director, Scripps Translational Science Institute; Executive VP and Professor, Molecular Medicine, The Scripps Research Institute
Moderator: Beth Kowitt, Senior Writer and Co-chair, MPW Next Gen, Fortune
Photograph by Stuart Isett/Fortune
003
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
2:20 PM
U.S. HEALTH CARE: AT THE CROSSROADS
A whole lot has changed since Mark Bertolini, back in 2010, took the helm at Aetna, the (now) $63 billion health insurer: The Affordable Care Act, barely then a law, has launched and (kind of) death spiraled. Opioids have become an acknowledged public health enemy. Wellness has become a corporate mantra. Big data, AI, and blockchain, once mere Silicon Valley buzzwords, have become ways of business that health care companies cannot ignore. The whole system has consolidated, while a formidable crew of outsiders—Google, Apple, Amazon—appear poised to disrupt everything. Bertolini has been at the center of it all—in an intimate and candid conversation with Fortune Editor-in-Chief Clifton Leaf, he’ll talk about navigating one of the nation’s largest health insurers (and the 43rd-largest public company in America) through these waters, and about his final act—Aetna’s transformational deal with CVS—and what it means about the future of health care in America.
Mark Bertolini, Chairman and CEO, Aetna Inc.
Interviewer: Clifton Leaf, Fortune
Photograph by Stuart Isett/Fortune
Fortune Brainstorm TECH
July 16th, 2014
Aspen, CO
7:45 AM
Disruptors Among Us
Garages and basements aren’t the only places hatching innovation.
Jeff Evenson, SVP , Corning
Keith Krach, CEO, DocuSign
Ebony Lee, VP, Strategic Development, Comcast
Alex Ljung, CEO, Soundcloud
Owen Mahoney, CEO, Nexon
Moderator: Michal Lev-Ram, Fortune
Photograph by Stuart Isett/Fortune Brainstorm TECH
042
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
4:30 PM
A SPECIAL CLOSING INTERVIEW: A CONVERSATION WITH KEVIN DURANT AND RICH KLEIMAN
Kevin Durant, Partner, The Durant Company; Thirty Five Media, Forward, Golden State Warriors
Rich Kleiman, Co-founder, The Durant Company; Thirty Five Media
Moderator:Arianna Huffington, Thrive Global
Photograph by Stuart Isett/Fortune
024
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
10:05 AM
WHO’S THE BOSS?
In the digital health revolution, the patient is supposed to be king. But in a world where this consumer doesn’t pay for much of his or her care, isn’t confident about his or her knowledge of the marketplace, and doesn’t have that much choice anyway, can he or she really be in charge? (If the answer is no, how do we change this paradigm?)
Dr. Valerie Montgomery Rice, President and Dean, Morehouse School of Medicine
Christi Shaw, President, Lilly Bio-Medicines
Dr. Eric Topol, Founder and Director, Scripps Translational Science Institute; Executive VP and Professor, Molecular Medicine, The Scripps Research Institute
Moderator: Beth Kowitt, Senior Writer and Co-chair, MPW Next Gen, Fortune
Photograph by Stuart Isett/Fortune
024
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
10:05 AM
WHO’S THE BOSS?
In the digital health revolution, the patient is supposed to be king. But in a world where this consumer doesn’t pay for much of his or her care, isn’t confident about his or her knowledge of the marketplace, and doesn’t have that much choice anyway, can he or she really be in charge? (If the answer is no, how do we change this paradigm?)
Dr. Valerie Montgomery Rice, President and Dean, Morehouse School of Medicine
Christi Shaw, President, Lilly Bio-Medicines
Dr. Eric Topol, Founder and Director, Scripps Translational Science Institute; Executive VP and Professor, Molecular Medicine, The Scripps Research Institute
Moderator: Beth Kowitt, Senior Writer and Co-chair, MPW Next Gen, Fortune
Photograph by Stuart Isett/Fortune
017
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
7:45 AM
CONCURRENT BREAKFAST SOLUTION SESSIONS
THE END OF HEALTH CARE PRIVACY… AND IS IT A GOOD THING?
Someone forgot to tell consumers to be careful. Over the past several years, people everywhere have zealously shared their intimate health data with products and services like 23AndMe, FitBit, and the Apple Watch—eager to be guinea pigs in the grand Big Data Experiment of Human Health. But when it comes to the broader medical universe, a matrix of rules and proprietary interests have made discovery from this deep data reservoir restrictive and challenging. Some, likewise, blame the frustrating lack of interoperability in health systems on a misreading of privacy protections—as well as on the unwillingness of private companies to play in the same data sandbox. How do we harness our limitless health-related data while still protecting individual privacy? And here’s a provocative question to start us off: Is privacy all it’s cracked up to be?
Anu Acharya, CEO, Mapmygenome
Dr. Kevin Ban, Chief Medical Officer, athenahealth
Colin Hill, Co-Founder, Chairman and CEO, GNS Healthcare
Chrissa McFarlane, Chief Executive Officer, Patientory
Dr. Eric Topol, Founder and Director, Scripps Translational Science Institute; Executive VP and Professor, Molecular Medicine, The Scripps Research Institute
Hal Wolf, President and CEO, Healthcare Information and Management Systems Society
Moderator: Dr. David B. Agus, University of Southern California
Photograph by Stuart Isett/Fortune
011
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
5:10 PM
PRECISION MEDICINE: WHERE IT’S WORKING AND WHY
The tools of molecular medicine, today, are homing in on human disease with a precision that could only be imagined a decade ago. New advances in big data, genomic medicine, and supercomputing are paving the way for targeted, personalized treatment. What has been the clinical impact so far—and what can we really expect in the five years to come? A deep dive with three individuals who are putting these tools into practice.
Kathy Giusti, Founder, Multiple Myeloma Research Foundation (MMRF); Faculty Co-chair, Kraft Precision Medicine Accelerator, Harvard Business School
Othman Laraki, Co-Founder and CEO, Color
Dr. Vijay Pande, General Partner, Andreessen Horowitz
Moderator: Dr. David B. Agus, University of Southern California
Photograph by Stuart Isett/Fortune
030
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
12:10 PM
FROM CLOUD HOSPITALS TO HUMAN CELL PRINTING: HOW CHINA IS LEADING THE WAY
Chinese entrepreneurs and leaders are racing to develop health care solutions that can better serve the country’s 1.3 billion people—and much of the inspiration for these innovations is home-grown. As China takes leaps forward in digital connectivity, big data analytics, 3D printing, and artificial intelligence, other nations—including some industrial giants—are suddenly finding themselves in the slow lane, held back by budget cuts, red tape, and entrenched systems. Some insights from one health care pioneer on what it will take to stay competitive in the global race to innovate.
Dr. Jiren Liu, Chairman and CEO, Neusoft Corporation
Interviewer: Dr. David B. Agus, University of Southern California
Photograph by Stuart Isett/Fortune
Fortune Brainstorm HEALTH 2018
March 19-20, 2018
Laguna Niguel, CA
The third Fortune Brainstorm HEALTH conference will be held March 19-20, 2018 in Laguna Niguel. We will again convene a powerful new community of leaders at the forefront of the revolution that is underway in 21st century healthcare.
2017 speakers included Joseph R. Biden, Jr., 47th Vice President, United States, CEOs Chip Bergh of Levi Strauss & Co. Mark Bertolini of Aetna, Tom Hayes of Tyson Foods, Arianna Huffington of Thrive Global, John Mackey of Whole Foods, Mike McNamara of Flex, Denise Morrison of Campbell Soup, and Timothy Wentworth of Express Scripts, as well as Duke University Surgical Oncologist (and Time 100 honoree) Dr. Shelley Hwang, Tempus Co-founder and Chair Eric Lefkofsky, Stanford University School of Medicine Dean Dr. Lloyd Minor, Venrock Partner Dr. Bryan Roberts, and Human Longevity Co-founder and Executive Chair Dr. J. Craig Venter. They were joined by our co-chairs—Fortune Editor-in-Chief Clifton Leaf, Time Executive Editor Siobhan O’Connor and Dr. David Agus, one of the world’s most influential physicians.
Fortune Brainstorm HEALTH, in association with IBM Watson Health, gathers not only C-suite leaders of top companies, hospitals, insurers, and cutting-edge pharma and biotech companies, but also titans of venture capital, tech and telecom, and other industries, all of who are rapidly changing the face of health care. The forum covered four pillars—personal wellness, intervention, research, and the value chain. Our aim is not only to push some boundaries in each of these areas, but also to show how businesses, both established and new, can lead the way. And, yes, as with all of our Brainstorm events, Fortune will disseminate these ideas on our website, in the magazine, on social media, and beyond.
Photograph by Stuart Isett/Fortune
042
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
4:30 PM
A SPECIAL CLOSING INTERVIEW: A CONVERSATION WITH KEVIN DURANT AND RICH KLEIMAN
Kevin Durant, Partner, The Durant Company; Thirty Five Media, Forward, Golden State Warriors
Rich Kleiman, Co-founder, The Durant Company; Thirty Five Media
Moderator:Arianna Huffington, Thrive Global
Photograph by Stuart Isett/Fortune
009
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
4:40 PM
THE MOTHER OF INVENTION
Necessity isn’t the mother of invention, creativity is. But where do you find the special spark that can help transform a product from merely a “cool” piece of tech to a must-have that can change lives for the better? And, in an age when billions of dollars are being pumped into digital health and medical technology ventures, how can stakeholders identify the most promising innovations? A conversation with some of the most creative minds in the health space.
James Park, Co-founder and CEO, Fitbit
Dr. Martine Rothblatt, Chairman and Chief Executive Officer, United Therapeutics Corp.
Moderator: Sue Siegel, Chief Innovation Officer, GE; Chief Executive Officer, GE Ventures
Photograph by Stuart Isett/Fortune
Fortune Brainstorm HEALTH 2018
March 19-20, 2018
Laguna Niguel, CA
The third Fortune Brainstorm HEALTH conference will be held March 19-20, 2018 in Laguna Niguel. We will again convene a powerful new community of leaders at the forefront of the revolution that is underway in 21st century healthcare.
2017 speakers included Joseph R. Biden, Jr., 47th Vice President, United States, CEOs Chip Bergh of Levi Strauss & Co. Mark Bertolini of Aetna, Tom Hayes of Tyson Foods, Arianna Huffington of Thrive Global, John Mackey of Whole Foods, Mike McNamara of Flex, Denise Morrison of Campbell Soup, and Timothy Wentworth of Express Scripts, as well as Duke University Surgical Oncologist (and Time 100 honoree) Dr. Shelley Hwang, Tempus Co-founder and Chair Eric Lefkofsky, Stanford University School of Medicine Dean Dr. Lloyd Minor, Venrock Partner Dr. Bryan Roberts, and Human Longevity Co-founder and Executive Chair Dr. J. Craig Venter. They were joined by our co-chairs—Fortune Editor-in-Chief Clifton Leaf, Time Executive Editor Siobhan O’Connor and Dr. David Agus, one of the world’s most influential physicians.
Fortune Brainstorm HEALTH, in association with IBM Watson Health, gathers not only C-suite leaders of top companies, hospitals, insurers, and cutting-edge pharma and biotech companies, but also titans of venture capital, tech and telecom, and other industries, all of who are rapidly changing the face of health care. The forum covered four pillars—personal wellness, intervention, research, and the value chain. Our aim is not only to push some boundaries in each of these areas, but also to show how businesses, both established and new, can lead the way. And, yes, as with all of our Brainstorm events, Fortune will disseminate these ideas on our website, in the magazine, on social media, and beyond.
Photograph by Stuart Isett/Fortune
Fortune Brainstorm HEALTH 2018
March 19-20, 2018
Laguna Niguel, CA
The third Fortune Brainstorm HEALTH conference will be held March 19-20, 2018 in Laguna Niguel. We will again convene a powerful new community of leaders at the forefront of the revolution that is underway in 21st century healthcare.
2017 speakers included Joseph R. Biden, Jr., 47th Vice President, United States, CEOs Chip Bergh of Levi Strauss & Co. Mark Bertolini of Aetna, Tom Hayes of Tyson Foods, Arianna Huffington of Thrive Global, John Mackey of Whole Foods, Mike McNamara of Flex, Denise Morrison of Campbell Soup, and Timothy Wentworth of Express Scripts, as well as Duke University Surgical Oncologist (and Time 100 honoree) Dr. Shelley Hwang, Tempus Co-founder and Chair Eric Lefkofsky, Stanford University School of Medicine Dean Dr. Lloyd Minor, Venrock Partner Dr. Bryan Roberts, and Human Longevity Co-founder and Executive Chair Dr. J. Craig Venter. They were joined by our co-chairs—Fortune Editor-in-Chief Clifton Leaf, Time Executive Editor Siobhan O’Connor and Dr. David Agus, one of the world’s most influential physicians.
Fortune Brainstorm HEALTH, in association with IBM Watson Health, gathers not only C-suite leaders of top companies, hospitals, insurers, and cutting-edge pharma and biotech companies, but also titans of venture capital, tech and telecom, and other industries, all of who are rapidly changing the face of health care. The forum covered four pillars—personal wellness, intervention, research, and the value chain. Our aim is not only to push some boundaries in each of these areas, but also to show how businesses, both established and new, can lead the way. And, yes, as with all of our Brainstorm events, Fortune will disseminate these ideas on our website, in the magazine, on social media, and beyond.
Photograph by Stuart Isett/Fortune
034
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
1:00 PM
CONCURRENT LUNCH SOLUTION SESSIONS
HEALTH CARE AND THE FOURTH INDUSTRIAL REVOLUTION
Hosted by Herman Miller
The industrial revolutions of yore heralded a transition from hand-powered production methods to machine-driven ones and the advent of mass production. The next industrial revolution is a decidedly digital one—and its implications for health care may be more significant than for any other industry. Far beyond telemedicine, the digital age isn’t just changing how we do medicine, but also how we define it. From the health gig economy to AI-run hospitals to on-demand diagnostics, technology is prompting a never-ending question: Where will this fourth revolution take us next?
Hema Budaraju, Product Lead, Health, Facebook
Sally Daub, CEO, Enlitic
Sajid Rahman, CEO, Telenor Health
Dr. Roy Schoenberg, President and CEO, American Well
Owen Tripp, Co-Founder and CEO, Grand Rounds
Moderator: Dr. David B. Agus, University of Southern California
Introduction: Mike O’Toole, Senior Vice President of Sales, Herman Miller
Photograph by Stuart Isett/Fortune
035
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
1:00 PM
CONCURRENT LUNCH SOLUTION SESSIONS
PATIENT TRIALS WE CAN ACTUALLY LEARN FROM
Hosted by City of Hope
The cost to develop and gain FDA approval for a new drug today is more than $2.5 billion, according to the Tufts Center for the Study of Drug Development. Driving much of that cost are human clinical trials—a process that has long been the intellectual and regulatory scaffold supporting the drug development enterprise, and one that has barely changed over the past seven decades. Despite all that expenditure—which ultimately helps push up the price of medicines—we still often know little about whether even approved drugs will work in any one individual and why. Luckily, there are a number of innovative ideas for evaluating the safety and efficacy of new medicines that may give us more information, more quickly—and maybe even more cheaply too. A no-holds-barred roundtable.
Dr. Amy Abernethy, Chief Medical Officer, Chief Scientific Officer, and Senior Vice President, Oncology, Flatiron Health
Matt de Silva, Co-Founder, CEO and Director, Notable Labs
Kathy Giusti, Founder, Multiple Myeloma Research Foundation; Co-Chair, HBS Kraft Precision Medicine Accelerator
Dr. Linda Malkas, Professor and Associate Chair, Department of Molecular and Cellular Biology, City of Hope
Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation
Moderator: Clifton Leaf, Fortune
Photograph by Stuart Isett/Fortune
035
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
1:00 PM
CONCURRENT LUNCH SOLUTION SESSIONS
PATIENT TRIALS WE CAN ACTUALLY LEARN FROM
Hosted by City of Hope
The cost to develop and gain FDA approval for a new drug today is more than $2.5 billion, according to the Tufts Center for the Study of Drug Development. Driving much of that cost are human clinical trials—a process that has long been the intellectual and regulatory scaffold supporting the drug development enterprise, and one that has barely changed over the past seven decades. Despite all that expenditure—which ultimately helps push up the price of medicines—we still often know little about whether even approved drugs will work in any one individual and why. Luckily, there are a number of innovative ideas for evaluating the safety and efficacy of new medicines that may give us more information, more quickly—and maybe even more cheaply too. A no-holds-barred roundtable.
Dr. Amy Abernethy, Chief Medical Officer, Chief Scientific Officer, and Senior Vice President, Oncology, Flatiron Health
Matt de Silva, Co-Founder, CEO and Director, Notable Labs
Kathy Giusti, Founder, Multiple Myeloma Research Foundation; Co-Chair, HBS Kraft Precision Medicine Accelerator
Dr. Linda Malkas, Professor and Associate Chair, Department of Molecular and Cellular Biology, City of Hope
Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation
Moderator: Clifton Leaf, Fortune
Photograph by Stuart Isett/Fortune
Fortune Brainstorm HEALTH 2018
March 19-20, 2018
Laguna Niguel, CA
The third Fortune Brainstorm HEALTH conference will be held March 19-20, 2018 in Laguna Niguel. We will again convene a powerful new community of leaders at the forefront of the revolution that is underway in 21st century healthcare.
2017 speakers included Joseph R. Biden, Jr., 47th Vice President, United States, CEOs Chip Bergh of Levi Strauss & Co. Mark Bertolini of Aetna, Tom Hayes of Tyson Foods, Arianna Huffington of Thrive Global, John Mackey of Whole Foods, Mike McNamara of Flex, Denise Morrison of Campbell Soup, and Timothy Wentworth of Express Scripts, as well as Duke University Surgical Oncologist (and Time 100 honoree) Dr. Shelley Hwang, Tempus Co-founder and Chair Eric Lefkofsky, Stanford University School of Medicine Dean Dr. Lloyd Minor, Venrock Partner Dr. Bryan Roberts, and Human Longevity Co-founder and Executive Chair Dr. J. Craig Venter. They were joined by our co-chairs—Fortune Editor-in-Chief Clifton Leaf, Time Executive Editor Siobhan O’Connor and Dr. David Agus, one of the world’s most influential physicians.
Fortune Brainstorm HEALTH, in association with IBM Watson Health, gathers not only C-suite leaders of top companies, hospitals, insurers, and cutting-edge pharma and biotech companies, but also titans of venture capital, tech and telecom, and other industries, all of who are rapidly changing the face of health care. The forum covered four pillars—personal wellness, intervention, research, and the value chain. Our aim is not only to push some boundaries in each of these areas, but also to show how businesses, both established and new, can lead the way. And, yes, as with all of our Brainstorm events, Fortune will disseminate these ideas on our website, in the magazine, on social media, and beyond.
Photograph by Stuart Isett/Fortune
042
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
4:30 PM
A SPECIAL CLOSING INTERVIEW: A CONVERSATION WITH KEVIN DURANT AND RICH KLEIMAN
Kevin Durant, Partner, The Durant Company; Thirty Five Media, Forward, Golden State Warriors
Rich Kleiman, Co-founder, The Durant Company; Thirty Five Media
Moderator:Arianna Huffington, Thrive Global
Photograph by Stuart Isett/Fortune
Fortune Brainstorm HEALTH 2018
March 19-20, 2018
Laguna Niguel, CA
The third Fortune Brainstorm HEALTH conference will be held March 19-20, 2018 in Laguna Niguel. We will again convene a powerful new community of leaders at the forefront of the revolution that is underway in 21st century healthcare.
2017 speakers included Joseph R. Biden, Jr., 47th Vice President, United States, CEOs Chip Bergh of Levi Strauss & Co. Mark Bertolini of Aetna, Tom Hayes of Tyson Foods, Arianna Huffington of Thrive Global, John Mackey of Whole Foods, Mike McNamara of Flex, Denise Morrison of Campbell Soup, and Timothy Wentworth of Express Scripts, as well as Duke University Surgical Oncologist (and Time 100 honoree) Dr. Shelley Hwang, Tempus Co-founder and Chair Eric Lefkofsky, Stanford University School of Medicine Dean Dr. Lloyd Minor, Venrock Partner Dr. Bryan Roberts, and Human Longevity Co-founder and Executive Chair Dr. J. Craig Venter. They were joined by our co-chairs—Fortune Editor-in-Chief Clifton Leaf, Time Executive Editor Siobhan O’Connor and Dr. David Agus, one of the world’s most influential physicians.
Fortune Brainstorm HEALTH, in association with IBM Watson Health, gathers not only C-suite leaders of top companies, hospitals, insurers, and cutting-edge pharma and biotech companies, but also titans of venture capital, tech and telecom, and other industries, all of who are rapidly changing the face of health care. The forum covered four pillars—personal wellness, intervention, research, and the value chain. Our aim is not only to push some boundaries in each of these areas, but also to show how businesses, both established and new, can lead the way. And, yes, as with all of our Brainstorm events, Fortune will disseminate these ideas on our website, in the magazine, on social media, and beyond.
Photograph by Stuart Isett/Fortune
Fortune Brainstorm HEALTH 2018
March 19-20, 2018
Laguna Niguel, CA
The third Fortune Brainstorm HEALTH conference will be held March 19-20, 2018 in Laguna Niguel. We will again convene a powerful new community of leaders at the forefront of the revolution that is underway in 21st century healthcare.
2017 speakers included Joseph R. Biden, Jr., 47th Vice President, United States, CEOs Chip Bergh of Levi Strauss & Co. Mark Bertolini of Aetna, Tom Hayes of Tyson Foods, Arianna Huffington of Thrive Global, John Mackey of Whole Foods, Mike McNamara of Flex, Denise Morrison of Campbell Soup, and Timothy Wentworth of Express Scripts, as well as Duke University Surgical Oncologist (and Time 100 honoree) Dr. Shelley Hwang, Tempus Co-founder and Chair Eric Lefkofsky, Stanford University School of Medicine Dean Dr. Lloyd Minor, Venrock Partner Dr. Bryan Roberts, and Human Longevity Co-founder and Executive Chair Dr. J. Craig Venter. They were joined by our co-chairs—Fortune Editor-in-Chief Clifton Leaf, Time Executive Editor Siobhan O’Connor and Dr. David Agus, one of the world’s most influential physicians.
Fortune Brainstorm HEALTH, in association with IBM Watson Health, gathers not only C-suite leaders of top companies, hospitals, insurers, and cutting-edge pharma and biotech companies, but also titans of venture capital, tech and telecom, and other industries, all of who are rapidly changing the face of health care. The forum covered four pillars—personal wellness, intervention, research, and the value chain. Our aim is not only to push some boundaries in each of these areas, but also to show how businesses, both established and new, can lead the way. And, yes, as with all of our Brainstorm events, Fortune will disseminate these ideas on our website, in the magazine, on social media, and beyond.
Photograph by Stuart Isett/Fortune
042
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
4:30 PM
A SPECIAL CLOSING INTERVIEW: A CONVERSATION WITH KEVIN DURANT AND RICH KLEIMAN
Kevin Durant, Partner, The Durant Company; Thirty Five Media, Forward, Golden State Warriors
Rich Kleiman, Co-founder, The Durant Company; Thirty Five Media
Moderator:Arianna Huffington, Thrive Global
Photograph by Stuart Isett/Fortune
040
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
3:35 PM
WHY DON’T WE TALK ABOUT DEATH?
Consider this: 70 percent of Americans want to die at home. Only 30 percent do. And yet we spend an awful lot of money giving people an end of life they don’t want: Medicare, for instance, spends nearly 30 percent of its annual outlays on individuals in the last year of their lives. Meanwhile, caregivers shoulder an enormous burden as they help loved ones in their final months and years. How did we end up here? One reason: we don’t talk about it. Well, guess what: we’re about to start.
Alexandra Drane, Co-founder, ARCHANGELS; Co-founder, Eliza Corporation
Michael Hebb, Founder, Death over Dinner
Venerable Tenzin Priyadarshi, Director, Ethics Initiative, MIT Media Lab
Moderator: Arianna Huffington, Thrive Global
Photograph by Stuart Isett/Fortune
Fortune Brainstorm HEALTH 2018
March 19-20, 2018
Laguna Niguel, CA
The third Fortune Brainstorm HEALTH conference will be held March 19-20, 2018 in Laguna Niguel. We will again convene a powerful new community of leaders at the forefront of the revolution that is underway in 21st century healthcare.
2017 speakers included Joseph R. Biden, Jr., 47th Vice President, United States, CEOs Chip Bergh of Levi Strauss & Co. Mark Bertolini of Aetna, Tom Hayes of Tyson Foods, Arianna Huffington of Thrive Global, John Mackey of Whole Foods, Mike McNamara of Flex, Denise Morrison of Campbell Soup, and Timothy Wentworth of Express Scripts, as well as Duke University Surgical Oncologist (and Time 100 honoree) Dr. Shelley Hwang, Tempus Co-founder and Chair Eric Lefkofsky, Stanford University School of Medicine Dean Dr. Lloyd Minor, Venrock Partner Dr. Bryan Roberts, and Human Longevity Co-founder and Executive Chair Dr. J. Craig Venter. They were joined by our co-chairs—Fortune Editor-in-Chief Clifton Leaf, Time Executive Editor Siobhan O’Connor and Dr. David Agus, one of the world’s most influential physicians.
Fortune Brainstorm HEALTH, in association with IBM Watson Health, gathers not only C-suite leaders of top companies, hospitals, insurers, and cutting-edge pharma and biotech companies, but also titans of venture capital, tech and telecom, and other industries, all of who are rapidly changing the face of health care. The forum covered four pillars—personal wellness, intervention, research, and the value chain. Our aim is not only to push some boundaries in each of these areas, but also to show how businesses, both established and new, can lead the way. And, yes, as with all of our Brainstorm events, Fortune will disseminate these ideas on our website, in the magazine, on social media, and beyond.
Photograph by Stuart Isett/Fortune
024
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
10:05 AM
WHO’S THE BOSS?
In the digital health revolution, the patient is supposed to be king. But in a world where this consumer doesn’t pay for much of his or her care, isn’t confident about his or her knowledge of the marketplace, and doesn’t have that much choice anyway, can he or she really be in charge? (If the answer is no, how do we change this paradigm?)
Dr. Valerie Montgomery Rice, President and Dean, Morehouse School of Medicine
Christi Shaw, President, Lilly Bio-Medicines
Dr. Eric Topol, Founder and Director, Scripps Translational Science Institute; Executive VP and Professor, Molecular Medicine, The Scripps Research Institute
Moderator: Beth Kowitt, Senior Writer and Co-chair, MPW Next Gen, Fortune
Photograph by Stuart Isett/Fortune
026
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
11:10 AM
A MOTHER FIGHTS BACK: USING BIG DATA AND GENOMICS TO SILENCE HER SON’S KILLER
Theresa Beech’s 13-year-old son Daniel died nearly two years ago from osteosarcoma. Daniel’s killer: a pediatric bone cancer whose treatment—and survival rates—haven’t changed in 30 years. But the time for change is now. Driven by the hope that she can spare other families this same pain and loss, Theresa — a space engineer by day — has collected the genetic codes from more than 100 young patients whose parents donated the data. What she has discovered offers hope for progress at last. The unbelievable story of one woman’s race to cure a terrible cancer.
Theresa Beech, President, Because of Daniel
Photograph by Stuart Isett/Fortune
024
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
10:05 AM
WHO’S THE BOSS?
In the digital health revolution, the patient is supposed to be king. But in a world where this consumer doesn’t pay for much of his or her care, isn’t confident about his or her knowledge of the marketplace, and doesn’t have that much choice anyway, can he or she really be in charge? (If the answer is no, how do we change this paradigm?)
Dr. Valerie Montgomery Rice, President and Dean, Morehouse School of Medicine
Christi Shaw, President, Lilly Bio-Medicines
Dr. Eric Topol, Founder and Director, Scripps Translational Science Institute; Executive VP and Professor, Molecular Medicine, The Scripps Research Institute
Moderator: Beth Kowitt, Senior Writer and Co-chair, MPW Next Gen, Fortune
Photograph by Stuart Isett/Fortune
040
FORTUNE Brainstorm Tech
December 1st, 2021
Half Moon Bay, CA
12:30 PM
LUNCH ROUNDTABLES
CONNECTING WITH YOUR CUSTOMERS
With a pandemic and intense political divisions—not to mention ever-evolving digital tools—connecting with your customers has never been more complex. But this can also be a time for brands to reach out with meaningful messages, to be authentic and transparent, and to embrace a more inclusive vision. We hear from a diverse range of leaders on how their engagement with customers has shifted.
Julia Hartz, Co-founder and CEO, Eventbrite
Steven Wolfe Pereira, Co-founder and CEO, Encantos
Cathy Polinsky, Vice President, Engineering, Shopify
Moderator: Phil Wahba, FORTUNE
Photograph by Nick Otto for FORTUNE BRAINSTORM TECH
001
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
11:30 AM–1:00 PM
OPENING LUNCH: THE MOMENT OF TRUTH FOR DRUG DEVELOPMENT
Hosted by PAREXEL
The rising cost of failure. Lack of productivity gains. Intense pressure on prices and escalating demands to demonstrate value. All these factors are threatening the sustainability of pharmaceutical development, at a time when advances in medical science should be translating into significant gains for the industry and society. But a new class of technologies and patient-centric approaches may soon alter the playing field in a big way, allowing drug developers to leverage everything from real world data, to the use of precision medicine and cross-silo collaboration—driving up success rates and the value proposition for new medicines. We dig into the latest marvels in pharmaceutical development, discuss new research findings and probe how the transformative role of data might prove decisive for the future of the industry.
Dr. Udit Batra, CEO, MilliporeSigma
David Humphreys, Head of Healthcare U.S., Economist Intelligence Unit
Bernard Munos, Senior Fellow, FasterCures, a center of the Milken Institute
Paul Rejto, Executive Director and Head of Oncology Translational Research, Pfizer
Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation
Moderator: Clifton Leaf, Editor-in-Chief, Fortune and Co-chair, Brainstorm Health
Introduction by: Dr. Alberto Grignolo, Corporate Vice President, Global Strategy, PAREXEL Consulting
Photograph by Stuart Isett/Fortune